News
People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...
The task force determines which preventive services insurers must cover at no cost to patients.
CAN Community Health has opened a new Norfolk clinic to expand free HIV care and reduce stigma in the community.
To find out what may be behind these numbers, Dr. Ann Khalsa, a clinician at the Valleywise Health McDowell Clinic spoke with ...
Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting ...
Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.
An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...
The Trump administration has eliminated some grants aimed at HIV education and prevention and cut funding at the Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results